AIP
TLSI icon

Ameritas Investment Partners’s TriSalus Life Sciences TLSI Stock Holding History

Ameritas Investment Partners’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Buy
4,350
+2,721
+167% +$10.8K ﹤0.01% 2760
2026
Q1 		$6.52K Hold
1,629
– – ﹤0.01% 2945
2025
Q4 		$11.4K Hold
1,629
– – ﹤0.01% 2870
2025
Q3 		$7.58K Hold
1,629
– – ﹤0.01% 2999
2025
Q2 		$8.88K Buy
+1,629
New +$8.74K ﹤0.01% 3014

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Ameritas Investment Partners's TLSI Position: Q2 2026 in Review

Ameritas Investment Partners increased its TriSalus Life Sciences (TLSI) stake by 167% in Q2 2026, buying an estimated $10.8K and bringing the position to 4,350 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2760.

Ameritas Investment Partners first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Ameritas Investment Partners held 4,350 shares of TriSalus Life Sciences worth $19.8K as of Q2 2026.
  • Ameritas Investment Partners bought 2,721 TriSalus Life Sciences shares in Q2 2026, an estimated $10.8K.
  • TriSalus Life Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2760 holding.
  • Ameritas Investment Partners first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.